Citation Impact
Citing Papers
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer
2006
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Dendritic cells as therapeutic vaccines against cancer
2005
Dendritic cells: On the move from bench to bedside
2001
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inflammation and cancer
2002 StandoutNature
Promiscuous and allele-specific anchors in HLA-DR-binding peptides
1993
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
Irreversible association of peptides with class II MHC molecules in living cells
1992 Nature
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Cloning and expression of a cDNA encoding an endothelin receptor
1990 StandoutNature
Immunology and immunotherapy approaches for prostate cancer
2007
Signaling Pathways Leading to Transcription and Translation Cooperatively Regulate the Transient Increase in Expression of c-Fos Protein
2001 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
The use of dendritic cells in cancer immunotherapy
2003 StandoutNobel
Cervical cancer vaccines: Emerging concepts and developments
2001
Developmental regulation of MHC class II transport in mouse dendritic cells
1997 StandoutNatureNobel
Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study
2005
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
2004 StandoutNobel
Immunogenicity of induced pluripotent stem cells
2011 StandoutNature
Massive Expansion of Antigen-Specific CD8+ T Cells during an Acute Virus Infection
1998
Regulated expression and phosphorylation of a possible mammalian cell-cycle control protein
1988 StandoutNatureNobel
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
1993 StandoutNature
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Some interfaces of dendritic cell biology
2003 StandoutNobel
Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides
1994
Integrated data from 2 randomized, double‐blind, placebo‐controlled, phase 3 trials of active cellular immunotherapy with sipuleucel‐T in advanced prostate cancer
2009
Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses
2002
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Immunotherapy for prostate cancer
2006
CD54 is a surrogate marker of antigen presenting cell activation
2008
Cancer immunotherapy comes of age
2011 StandoutNature
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Spinning molecular immunology into successful immunotherapy
2002
Therapeutic vaccines for cancer: an overview of clinical trials
2014
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
2000 StandoutNature
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors
2002
Immunotherapy for prostate cancer
2007
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein–Barr virus nuclear antigen 1
1997 StandoutNobel
Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells.
2002
The cancer vaccine roller coaster
2009
Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
1994
New Approaches to Immunotherapy for HPV Associated Cancers
2011
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
1993
Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells.
1983 Standout
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Inositol trisphosphate, a novel second messenger in cellular signal transduction
1984 StandoutNature
A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts
1989
Ectopic Expression of the Serotonin 1c Receptor and the Triggering of Malignant Transformation
1989 StandoutScienceNobel
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
2001 StandoutScience
Selective expression of the p70 subunit of the interleukin-2 receptor on lymphocytes from patients with infectious mononucleosis
1990
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
1998 StandoutNature
Network of dendritic cells within the muscular layer of the mouse intestine
2005 StandoutNobel
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
1993
Ionic responses rapidly elicited by porcine platelet-derived growth factor in Swiss 3T3 cells.
1984
Early Signals in the Mitogenic Response
1986 Science
Wound Healing--Aiming for Perfect Skin Regeneration
1997 StandoutScience
Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.
1996
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.
1986
Novel Regulators of Bone Formation: Molecular Clones and Activities
1988 StandoutScience
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Stress relaxation of fibroblasts activates a cyclic AMP signaling pathway.
1994
Mitogenic and oncogenic properties of the small G protein Rap1b
1998
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
1989 StandoutScience
Biochemical evidence for a third chain of the interleukin-2 receptor.
1991 StandoutNobel
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
G 1 Events and Regulation of Cell Proliferation
1989 StandoutScience
Post-transcriptional control of the onset of DNA synthesis by an insulin-like growth factor.
1984
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Intracellular K+ and the mitogenic response of 3T3 cells to peptide factors in serum-free medium.
1982
Depletion of intracellular potassium arrests coated pit formation and receptor-mediated endocytosis in fibroblasts
1983 StandoutNobel
Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
1998
A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer
2007 StandoutNobel
Antigen Presentation and T Cell Stimulation by Dendritic Cells
2002
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors
2002
Structure of Peptides Associated with Class I and Class II MHC Molecules
1994
Immunological Memory and Protective Immunity: Understanding Their Relation
1996 StandoutScience
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
1984 StandoutNature
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Works of George Strang being referenced
Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell Srfaces
1990
Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity
1990
Multiple HLA class I‐dependent cytotoxicities constitute the “non‐HLA‐restricted” response in infectious mononucleosis
1987
Cyclic AMP: a mitogenic signal for Swiss 3T3 cells.
1981
In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
1987
Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy
2001
Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells
2000
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.
2000